{"id":"W2739450515","doi":"10.1177/1753465817717134","title":"Reslizumab in the treatment of inadequately controlled asthma in adults and adolescents with elevated blood eosinophils: clinical trial evidence and future prospects","year":2017,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Teva Pharmaceutical Industries; Merck","keywords":"Benralizumab; Medicine; Mepolizumab; Asthma; Eosinophil; Endotype; Immunology; Tolerability; Eosinophilia; Placebo; Internal medicine; Adverse effect; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008808692,0.0007765712,0.003506822,0.0004284207,0.0001004109,0.00004986016,0.0003718472,0.0003429136,0.000005607411],"category_scores_gemma":[0.0003341264,0.0004128837,0.0003747134,0.0003988664,0.0008034352,0.0002822452,0.00004474677,0.0005791362,0.000001476546],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001385017,"about_ca_system_score_gemma":0.001323675,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006707047,"about_ca_topic_score_gemma":0.0001010815,"domain_scores_codex":[0.9944637,0.001657497,0.001796512,0.001010086,0.0005849399,0.000487294],"domain_scores_gemma":[0.9967391,0.000535258,0.001168453,0.001101816,0.00009194694,0.0003633938],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.1433113,0.003941847,0.0285971,0.01098429,0.0001117244,0.0011882,0.0001560901,6.949899e-7,1.241362e-7,0.00003199461,6.133114e-7,0.811676],"study_design_scores_gemma":[0.3193868,0.01826016,0.07984242,0.1312685,0.003346668,0.0000312337,0.0003346071,0.00001537039,5.829999e-7,0.0001285043,0.4464506,0.0009346238],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.127505,0.8641887,4.170459e-7,0.000057436,0.0001277901,0.008052641,0.00003287228,0.00001721955,0.00001789093],"genre_scores_gemma":[0.1469688,0.8512924,0.000006427102,0.0001729117,0.0004855052,0.001002171,0.000009709932,0.00005386458,0.000008235117],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8107414,"threshold_uncertainty_score":0.9998323,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1004534049370695,"score_gpt":0.427334420223989,"score_spread":0.3268810152869196,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}